Pharmaceutical Applications of Therapeutic Deep Eutectic Systems (THEDES)

Dear Colleagues,

Therapeutic deep eutectic systems (THEDESs) have emerged as a promising class of systems and matrices within the pharmaceutical field, offering remarkable advantages such as improved drug bioavailability (including solubility and permeability), stability, biocompatibility, and selectivity towards the therapeutic target.

These eutectics can be tailored for diverse pharmaceutical applications, ranging from transdermal to oral drug delivery, and encompass a myriad of applications, including antimicrobial, antioxidant, anticancer, wound-healing enhancers, and anti-inflammatory agents, among others. Their compatibility with both synthetic and natural active pharmaceutical ingredients (APIs) further expands their scope, making them highly attractive for innovation in formulation science.

This Special Issue aims to showcase the latest advances in the design, characterization, and pharmaceutical application of THEDES. We welcome original research articles and comprehensive reviews that contribute to understanding the potential and challenges of THEDES in pharmaceutical sciences.

We invite researchers working across biomedicine, formulation science, drug delivery, green chemistry, and related disciplines to contribute their findings and perspectives.

We look forward to your valuable contributions.

Dr. Filipe Oliveira
Dr. Laura Lomba Eraso
Prof. Dr. Yohann Corvis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.